CASE PRESENTATION
A 74-year-old woman was admitted to hospital in August 2010 for community-acquired pneumonia. Laboratory investigations revealed iron deficiency anemia (hemoglobin 104 g/L) and a thoracic computed tomography scan revealed scattered bilateral nodular opacities compatible with pulmonary metastasis of unknown primary site. In the diagnostic workup, the colonoscopy revealed a 40 mm vegetating lesion with a brownish surface at the distal rectum involving the anorectal transition (Figures 1 and 2 ). Histological analysis revealed an ulcerated malignancy with pleomorphic epithelioid cells and abundant melanophages (Figures 3 and 4) . Immunohistochemical staining was positive for S-100, HMB-45 and Melan-A proteins, establishing the diagnosis of anorectal melanoma. She also had brain metastases. Due to the global status, symptomatic treatment was proposed. The patient died six months later.
DISCUSSION
Primary anorectal melanoma is a rare and aggressive disease, representing <1% of all melanomas, and approximately 0.5% to 2% of all anorectal malignancies (1). It is slightly more predominant in females, primarily in the fifth and sixth decades of life (1) . The tumour can arise directly from melanocytes located above the dentate line, where there are abundant lymphatics and blood vessels that enable the tumour to grow and metastize quickly (2) . It usually presents with symptoms such as rectal bleeding, anorectal pain, rectal mass or change in bowel habits (1). It has a very poor prognosis. The mean survival after diagnosis is 15 to 25 months. At diagnosis, >20% have distant metastases (3) .
The optimal treatment is controversial. Surgical resection is the conventional therapy and includes abdominoperineal resection and wide local excision with or without adjuvant therapy (1,3). The Canadian Journal of Gastroenterology & Hepatology is considering a limited number of submissions for IMAGE OF THE MONTH. These are based on endoscopic, histological, radiological and/or patient images, which must be anonymous with no identifying features visible. The patient must consent to publication and the consent must be submitted with the manuscript. All manuscripts should be practical and relevant to clinical practice, and not simply a case report of an esoteric condition. The text should be brief, structured as CASE PRESENTATION and DISCUSSION, and not more than 700 words in length. A maximum of three images can be submitted and the number of references should not exceed five. The submission may be edited by our editorial team.
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